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Abstract
Background Elderly residents of long-term care facilities
are more vulnerable to being prescribed inappropriate
medications because of the high incidence of co-medica-
tion in this population resulting from the presence of
multiple chronic diseases and also age-related changes in
pharmacokinetics and pharmacodynamics.
Objective We evaluated the frequency of potentially
inappropriate medications and factors influencing their
frequency.
Methods A retrospective cross-sectional study was con-
ducted in 20 long-term care facilities located in the
northwest regions of South Korea for 824 patients aged
65 years and older who were assessed between January and
February of 2012. Potentially inappropriate medications
were identified using the 2012 American Geriatric Soci-
ety’s Beers Criteria. We assessed the relationship between
the frequency of potentially inappropriate medications
prescribed and patient age, sex, co-medications, comor-
bidity, activities of daily living, length of stay, grade of
long-term care insurance for seniors, and the bed size and
business type of the long-term care facility.
Results Of the 529 participants who satisfied our inclusion
criteria, 308 (58.2 %) had received at least one inappropriate
medication according to the 2012 Beers Criteria. The most
frequently prescribed classes of inappropriate medications
were central nervous system drugs (58.7 %), anti-cholinergics
(21.2 %), and cardiovascular medications (10.8 %). The most
commonly used drugs were quetiapine (28.4 %), chlorpheni-
ramine (15.8 %), risperidone (6.5 %), and zolpidem (5.8 %).
Inappropriate medication use was associated with the number
of co-medications and long-term care insurance grade 3, which
means less dependence and a requirement of low-level care.
Conclusions Central nervous system drugs (58.7 %) were
the most prescribed class of inappropriate medications.
Quetiapine was the drug most often given inappropriately
(28.4 %). There was a relationship between inappropriate
medication use and the number of co-medications. The
frequency of inappropriate medication prescriptions was
higher among patients whose long-term care insurance for
seniors was grade 3, which means less dependence and a
requirement of low-level care.
Key Points
Central nervous system drugs (58.7 %) were the
most prescribed class of inappropriate medications in
Korean long-term care facilities.
Inappropriate medication use was associated with the
number of co-medications and long-term care
insurance grade 3, which means less dependence and
a requirement of low-level care.
Effective management of nursing home residents
belonging to long-term care grade 3 via reducing
potentially inappropriate medications is considered.
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1 Introduction
Korea became an ‘‘aging society’’ in 2000, and in 2008, the
prevalence of individuals aged 65 years or older was
10.3 %. In 2018, Korea will become an ‘‘aged society’’
when 14.4 % of its population comprise the elderly, and a
‘‘super-aged society’’ by 2026 [1, 2]. To overcome this
situation, the Korean Government introduced a new social
insurance scheme for long-term care (LTC) in July 2008
[3]. The LTC Insurance Program provides social services
for elderly people with a few functional limitations. The
purpose of this insurance system was to meet the markedly
increased demand for elderly healthcare as a result of a
rapidly aging population, elevated expectations for
healthcare, and a change in the pattern of medical condi-
tions in the elderly from acute illness to chronic disability.
This insurance uses the LTC grade for denoting how much
help is required for an elderly person in their daily lives.
After the implementation of LTC insurance, the number of
nursing facilities in Korea also increased sharply from
1717 locations (68,581 people) in 2008 to 3751 locations
(116,782 people) [4].
Researchers have documented the widespread incidence
of inappropriate medication use in elderly persons and
reported an estimated prevalence from 4.8 to 45.6 % [5–
11]. The proper use of medicines and monitoring for
adverse effects are important factors in the treatment of
elderly patients. Aging is associated with a reduction in
first-pass metabolism and therefore an increase in the
bioavailability and distribution of drugs, which increases
the risk of adverse effects; these risks grow exponentially
when a number of different drugs are used. Because of the
potentially serious consequences of exaggerated or incor-
rect prescriptions, screening tools have been created to
detect inadequacies in drug prescriptions. In 2012, the
American Geriatrics Society (AGS) and an interdisci-
plinary panel of experts in geriatric care and pharma-
cotherapy reached a consensus on the 2012 AGS Beers
Criteria [12]. Fifty-three medications or medication classes
encompass the final updated criteria, which are divided into
three categories: potentially inappropriate medications
(PIMs) or classes to avoid in older adults; PIMs or classes
to avoid in older adults with certain diseases and syn-
dromes that the listed drugs can exacerbate; and medica-
tions to be used with caution in older adults. Elderly
nursing home residents regularly receive complex multi-
drug therapy because of the presence of both acute and
chronic diseases. For this reason, inappropriate medication
use is a major patient safety concern, especially for the
elderly [13].
There have been few reports dealing with the prevalence
of PIM prescriptions or their adverse effects on elderly
patients in South Korea [14, 15]. To our knowledge, there
have been no reports on the prevalence of PIM prescrip-
tions in South Korea LTC facilities using the 2012 version
of the Beers criteria. Hence, we evaluate the frequency of
inappropriate medication use in elderly patients admitted to
nursing homes in Korea by applying the newly revised
2012 AGS Beers Criteria. In addition, the characteristics
and risk factors for such prescribing were investigated.
2 Methods
A retrospective cross-sectional survey study was performed
in patients aged 65 years or older, which produced a
sample of 824 people admitted to 20 nursing facilities in
northwest Korea from January 2012 to February 2012. We
excluded four patients who did not take any medications,
259 patients with incomplete medical records, and 32
patients who were not included in any LTCI programs. The
participants’ medical records were collected from the
record section of the institute. We assessed the patients’
age, sex, co-medication, comorbidity, activities of daily
living (ADL), length of stay, grade of LTC insurance for
seniors, and the bed size and business type of the LTC care
facilities. The LTC grade is based on standards of five
areas of physical functions (ADL), cognition, behavioral
changes (behavioral problems), demand on nursing care,
and need for rehabilitation, and judgment standards made
in consideration of service necessary according to the state
of functions. On a checklist with a maximum score of 100,
a score of 55 and over makes an individual eligible for
insured care. Categories of LTC grade are defined as fol-
lows [4]: grade 1 (most severe)—the elderly person has one
of the following handicaps: he or she cannot go to or get
out of bed unaided; experiences behavioral difficulties,
impaired judgment, and frequent memory loss as a result of
severe brain injury; or completely needs full assistance
with all the activities of daily life and records a LTC
acknowledgment score of at least 95; grade 2 (severe)—the
elderly person cannot eat, defecate nor dress themselves
unaided; has impaired judgment and memory loss due to
dementia; needs considerable help in moving or moving in
a wheelchair; spends most parts of daily life in bed and
records an LTC acknowledgment score of at least 75 but
less than 95; grade 3 (moderate)—the elderly person par-
tially needs considerable LTC protection; some degree of
help for eating, dressing/undressing, using the toilet,
looking after himself or herself, performing household
tasks, and performing their everyday activities outside the
home; and records an LTC acknowledgement score of at
least 55 but less than 75; no grade (mild)—the elderly
person needs some help in one or two activities of daily
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life, including bathing and dressing/undressing and records
an LTC acknowledgment score of less than 55.
Prescriptions were assessed for the use of PIMs
according to the 2012 AGS Beers Criteria [12]. We focused
on evaluating 34 PIMs to avoid in older adults and one of
the categories in the 2012 update to the AGS’s Beers
Criteria. Drug–disease interactions and drugs to be used
with caution in geriatric patients were also assessed using
the Beers Criteria [12]. Anti-cholinergics include
brompheniramine, carbinoxamine, chlorpheniramine,
clemastine, cyproheptadine, dexbrompheniramine, dex-
chlorpheniramine, diphenhydramine (oral), doxylamine,
hydroxyzine, promethazine, and triprolidine. Cardiovas-
cular medications include alpha blockers, alpha agonists,
guanabenz, guanfacine, methyldopa, reserpine
([0.1 mg/day), anti-arrhythmic drugs (Class Ia, Ic, III),
and amiodarone. Central nervous system drugs include
tertiary tricyclic antidepressants, antipsychotics, barbitu-
rates, and benzodiazepines.
We calculated the descriptive statistics to illustrate char-
acteristics of the study population by comparing persons on
PIMs with those not on PIMs. The distributions of baseline
descriptive statistics are expressed as proportions and means
with standard deviations. In the case of categorical variables,
cross-tabulations with chi-square tests were used in com-
paring the differences. For continuous variables, the statis-
tically significant difference in means was determined by the
independent t test. Concurrent PIM use was defined as the
number of PIM prescriptions within an individual incidence
year. Logistic regression analysis was performed to identify
the risk factors for PIM exposure where PIM use (0 or 1) was
the dependent variable and the independent variables
included age, sex, ADL, length of stay, number of comor-
bidities, number of co-medications, and grade of LTC
insurance. Use of PIMs has been consistently associatedwith
female sex, higher number of medications, higher number of
chronic diseases, and older age [16–21]. Length of stay was
also found to significantly increase the risk of PIMs [22]. A
two-sided p value\0.05 was considered significant. All
statistical analyses were performed using SPSS 18.0 for
Windows (SPSS Inc., Chicago, IL, USA).
3 Results
This study recruited 529 patients; 221 of these did not use a
PIM, while the remaining 308 patients were currently
taking PIMs. Descriptive statistics for the incident PIM
cases are displayed in Table 1. Significant differences
between those prescribed and those not prescribed a PIM
were found for sex, age, deductible class, number of dif-
ferent medications used, number of chronic conditions,
total healthcare costs in the previous year, and number of
concurrent PIMs. The average number of medications in
the PIM group was 4.0 ± 2.3, while the non-PIM group’s
average number of medications was 6.4 ± 2.9 (p\ 0.001).
In addition, the average number of comorbidities was
3.3 ± 1.4 in the PIM group and 3.8 ± 1.5 in the non-PIM
group (p\ 0.001). The number of patients whose LTC
insurance for seniors was grade 3 was relatively higher in
the PIM group than it was in the non-PIM group. The six
most commonly prescribed classes of medicines within the
Anatomical Therapeutic Chemical classification system
were as follows: central nervous system (n = 930;
36.4 %), alimentary tract and metabolism (n = 553;
21.6 %), cardiovascular system (n = 388; 15.1 %), blood
and blood-forming organs (n = 236; 9.2 %), respiratory
system (n = 115; 4.5 %), and musculoskeletal system
(n = 72; 2.8 %). Table 2 presents the number of PIMs
prescribed in LTC facilities.
The six most commonly prescribed classes of medica-
tions in our patients were as follows: central nervous sys-
tem (n = 271; 58.7 %), anticholinergics (n = 98; 21.2 %),
cardiovascular system (n = 50; 10.8 %), endocrine system
(n = 22; 4.8 %), analgesics (n = 9; 1.9 %), and anti-
parkinsonian drugs (n = 9; 1.9 %) (Table 3). Specifically,
the most common PIM subtype was quetiapine (n = 131;
28.4 %), followed by chlorpheniramine (n = 73; 15.8 %),
risperidone (n = 30; 6.5 %), zolpidem (n = 27; 5.8 %),
and spironolactone (n = 26, 5.6 %) (Table 4). Multivariate
logistic regression analyses were applied, and the factors
that exhibited significant associations with PIM prescrip-
tions are shown in Table 5.
4 Discussion
The present study focuses on a growing public health
problem: inappropriate medication prescriptions in LTC
facilities. A disturbingly high level of PIMs were pre-
scribed (58.2 %), which is of concern, indicating room for
improvement. A comparison with the results from studies
conducted previously worldwide is not straightforward
owing to variations in methods, such as data and duration
of collection, study criteria, and characteristics of the
population groups. Despite these variations, this prevalence
was similar to those observed in the USA, with values of
49 % of elderly patients who were admitted with one or
more of the seven most common medical diagnoses [23]
and 55.3 % in those undergoing surgery during their hos-
pitalization [24], and 56.1 % of those in acute care hospi-
tals in Japan [25].
The results described in the multivariate analysis
regarding the factors associated with a potentially
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inappropriate prescription showed that the likelihood was
determined by the number of drugs prescribed during the
patient’s hospitalization. Some of these findings were in
line with those from previous research. In India, the
results of a logistic regression model showed that multiple
diseases and a higher use of drugs during hospital stay
predicted PIM prescription [26]. Multivariate analyses
also revealed that the number of drugs prescribed seemed
to be one of the most important independent predictors for
receiving an inappropriate medication [27, 28].
Furthermore, inappropriate medication use was higher
with the LTC insurance grade 3, which means less
dependence and a requirement of low-level care. This can
be explained by the fact that most of the residents in
Korean LTC facilities have been diagnosed with dementia
or another neurodegenerative disorder. Considering cen-
tral nervous system drugs (58.7 %) were the most pre-
scribed class of inappropriate medications, such
prescriptions are used to manage behavioral and psychi-
atric symptoms.
Table 1 General characteristics
of the residents in long-term
care facilities
Variables Non-PIMs [n = 221 (%)] PIMs [n = 308 (%)] P value
Age (years) 81.6 ± 8.9 80.2 ± 8.4 0.067
Sex (male) 64 (29.0%) 59 (19.2%) 0.080
Number of co-medications 4.0 ± 2.3 6.4 ± 2.9 \0.001a
0–3 105 (47.5%) 51 (16.6%)
4–5 82 (37.1%) 112 (36.4%)
6–7 32 (14.5%) 103 (33.4%)
C8 2 (0.9%) 42 (13.6%)
Number of co-morbidities 3.3 ± 1.4 3.77 ± 1.5 \0.001b
0–2 70 (31.7%) 58 (18.8%)
3 52 (23.5%) 90 (29.2%)
4 61 (27.6%) 66 (21.4%)
C 5 38 (17.2%) 94 (30.5%)
Number of ADLs 1.2 ± 1.2 1.3 ± 1.2 0.405
ADL
Bathing 8 (3.6%) 7 (2.3%) 0.357
Dressing 52 (23.5%) 62 (20.1%) 0.348
Eating 132 (59.7%) 209 (67.9%) 0.054
Toileting 58 (26.2%) 87 (28.2%) 0.611
Walking 22 (10.0%) 42 (13.6%) 0.200
Length of stay (months) 28.4 ± 25.9 26.7 ± 29.2 0.494
Grade of long-term care insurance for senior
1 38 (17.2%) 31 (10.1%) 0.008c
2 83 (37.6%) 100 (32.5%)
3 100 (45.2%) 177 (57.5%)
Bed size of long-term care facilities
\29 54 (24.4%) 74 (24.0%) 0.950d
30–59 66 (29.9%) 96 (31.2%)
C60 101 (45.7%) 138 (44.8%)
Business type of long-term care facilities
Corporation 159 (71.9%) 223 (72.4%) 0.908e
Private operator 62 (28.1%) 85 (27.6%)
Values are presented as number (%)
PIM potentially inappropriate medication, ADL activities of daily living
a P value applied to row 4–7 inclusive
b P value applied to row 9–12 inclusive
c P value applied to row 20–22 inclusive
d P value applied to row 23–25 inclusive
e P value applied to row 26–27 inclusive
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When interpreting the findings of the current study,
some limitations to the methodology that could bias esti-
mates are worth mentioning. The first limitation lies with
the fact that the study was cross sectional, which does not
allow us to identify the causal relationship of PIM with
associated factors in nature. Second, the Beers Criteria
have been examined extensively in research since their
development and found to be effective in identifying PIM
and advising close monitoring of certain medications.
However, evidence supporting the effectiveness of the
Beers Criteria in consistently reducing the adverse effects
of drugs or decreasing costs or mortality is lacking [29, 30].
The Beers Criteria does not take into account geriatric
patients in palliative care or hospice, does not detect pre-
scribing omissions, underuse of medications, inappropriate
dosing of medications, or duplication of drug classes [31,
32]. Third, although the information was gathered mainly
from a chart review, recall bias may have been a problem
because patients reported their current medications through
a structured interview that took place before admission,
including the duration of treatment and the dosage; this
information may have been inaccurate. Fourth, this sample
is unlikely to be representative of all Koreans because the
study was conducted in one region of the country and,
therefore, the ability to generalize the findings is
questionable.
Central nervous system drugs (58.7 %) were the most
prescribed class of inappropriate medications in Korean
LTC facilities. Inappropriate medication use was associ-
ated with the number of co-medications and LTC insurance
grade 3, which means less dependence and a requirement
of low-level care.
5 Conclusions
Central nervous system drugs (58.7 %) were the most pre-
scribed class of inappropriate medications. Quetiapine was
the drug most often given inappropriately (28.4 %). There
was a relationship between inappropriate medication use and
the number of co-medications. The frequency of inappro-
priate medication prescriptions was higher among patients
Table 2 Number of potentially inappropriate medications in the











Table 3 Six most commonly prescribed potentially inappropriate
medications classes
Medications class (ATC code) Number (%)
Central nervous system (N05-N06) 271 (58.7)
Anticholinergics (N04A) 98 (21.2)
Cardiovascular system (C) 50 (10.8)
Endocrine system (G03) 22 (4.8)
Analgesics (N02) 9 (1.9)
Anti-parkinsonian drugs (N04) 9 (1.9)
Medication classes are stratified according to 2012 American Geri-
atrics Society Beers Criteria for Potentially Inappropriate Medication
Use in Older Adults
( ) means codes of Anatomical Therapeutic Chemical (ATC)
Classification
Table 4 Prevalence of potentially inappropriate medications
according to individual drugs
Drugs (ATC code) Number (%)
Quetiapine (N05AH04) 131 (28.4)
Chlorpeniramine (R06AB04) 73 (15.8)
Risperidone (N05AX08) 30 (6.5)
Zolpidem (N05CF02) 27 (5.8)
Spironolactone (C03DA01) 26 (5.6)
Olanzapine (N05AH03) 21 (4.5)
Lorazepam (N05BA06) 19 (4.1)
Alprazolam (N05BA12) 16 (3.5)
Hydroxyzine (N05BB01) 13 (2.8)
Cyproheptadine (R06AX02) 12 (2.6)
Doxazosin (C02CA04) 12 (2.6)
Sliding Scale Insulin (A10AB01) 12 (2.6)
Amitriptyline (N06AA09) 11 (2.4)
Megestrol (G03AC05) 10 (2.2)
Meloxicam (N01AC06) 9 (1.9)
Benztropine (N04AC01) 7 (1.5)
Nifedipine (C08CA05) 7 (1.5)
Diazepam (N05BA01) 6 (1.3)
Clonazepam (N03AE01) 5 (1.1)
Terazosin (G04CA03) 3 (0.6)
Total 462 (100)
Medication classes are stratified according to 2012 American Geri-
atrics Society Beers Criteria for Potentially Inappropriate Medication
Use in Older Adults
( ) means codes of Anatomical Therapeutic Chemical (ATC)
Classification
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whose LTC insurance for seniors was grade 3, which means
less dependence and a requirement of low-level care.
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